Literature DB >> 7107407

Binding of misonidazole to EMt6 and V79 spheroids.

A J Franko, J D Chapman, C J Koch.   

Abstract

Metabolism-induced binding of misonidazole was shown previously to be enhanced in hypoxic regions of V79 spheroids. Data are presented to show that the binding of misonidazole to EMT6 spheroids is similar to V79 in some respects and different in others. The binding rate in nitrogen was constant in all cells in EMT6 spheroids, whereas a 5-fold rise was found in binding rate across the outer 100 micrometers of V79 spheroids. A small enhancement of binding to the cells near the necrotic center in EMT6 spheroids in air was found, which was similar to the binding to chronically hypoxic cells in aerobic V79 spheroids. The binding rate in 1--5% oxygen was similar in EMT6 and V79 spheroids. Both showed a large rise in binding rate across the outer 120 micrometers and a constant binding rate to healthy cells interior to this. Since 1.5 oxygen should supply only the outer 40 micrometers of a typical spheroid, something beyond a simple oxygen diffusion limitation is required to explain the data. One possible explanation is the diffusion of some of the reactive product away from the hypoxic cells which produce it. This was tested by incubating a single cell suspension in misonidazole at 0.5% oxygen in the presence of absence of V79 spheroids. No evidence was found for an appreciable loss of reactive product from the spheroids.

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 7107407     DOI: 10.1016/0360-3016(82)90724-6

Source DB:  PubMed          Journal:  Int J Radiat Oncol Biol Phys        ISSN: 0360-3016            Impact factor:   7.038


  6 in total

Review 1.  Multicellular spheroids. A review on cellular aggregates in cancer research.

Authors:  W Mueller-Klieser
Journal:  J Cancer Res Clin Oncol       Date:  1987       Impact factor: 4.553

2.  Binding of misonidazole to hypoxic cells in monolayer and spheroid culture: evidence that a side-chain label is bound as efficiently as a ring label.

Authors:  J A Raleigh; A J Franko; C J Koch; J L Born
Journal:  Br J Cancer       Date:  1985-02       Impact factor: 7.640

3.  Non-invasive assessment of human tumour hypoxia with 123I-iodoazomycin arabinoside: preliminary report of a clinical study.

Authors:  M B Parliament; J D Chapman; R C Urtasun; A J McEwan; L Golberg; J R Mercer; R H Mannan; L I Wiebe
Journal:  Br J Cancer       Date:  1992-01       Impact factor: 7.640

4.  Fluorescence immunohistochemical detection of hypoxic cells in spheroids and tumours.

Authors:  J A Raleigh; G G Miller; A J Franko; C J Koch; A F Fuciarelli; D A Kelly
Journal:  Br J Cancer       Date:  1987-10       Impact factor: 7.640

5.  Variable presence of hypoxia in M006 human glioma spheroids and in spheroids and xenografts of clonally derived sublines.

Authors:  A J Franko; M B Parliament; M J Allalunis-Turner; B G Wolokoff
Journal:  Br J Cancer       Date:  1998-11       Impact factor: 7.640

6.  A novel technique for measuring human tissue pO2 at the cellular level.

Authors:  R C Urtasun; C J Koch; A J Franko; J A Raleigh; J D Chapman
Journal:  Br J Cancer       Date:  1986-09       Impact factor: 7.640

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.